Orlistat Health Dictionary

Orlistat: From 3 Different Sources


An anti-obesity drug used with a slimming diet to treat severe obesity. Unlike appetite suppressants, orlistat acts on the gastrointestinal tract, preventing the digestion of fats by lipases (pancreatic enzymes). Instead of being absorbed, the fats pass out of the body in faeces.

Side effects are gastrointestinal and can be minimized by reducing fat intake.

Flatulence and faecal urgency are common.

Deficiencies of fat-soluble vitamins may develop with prolonged use.

Health Source: BMA Medical Dictionary
Author: The British Medical Association
An inhibitor of the pancreatic enzyme LIPASE, which breaks down fats in food to their constituent parts. By inhibiting lipase, the drug reduces absorption of dietary fat from the INTESTINE. It is used as an ADJUVANT to a modest low-calorie diet in people with a BODY MASS INDEX of 30 kg/m2 or more. The drug should be prescribed only if diet alone has, over a period of four consecutive weeks, resulted in a person losing 2.5 kg or more. Orlistat may cause oily liquid faeces, urgency to defecate, excessive wind and, sometimes, headaches, tiredness and anxiety. (See OBESITY.)
Health Source: Medical Dictionary
Author: Health Dictionary
n. a drug that reduces the absorption of fat in the stomach and small intestine by inhibiting the action of pancreatic *lipases. It is administered by mouth in the treatment of clinical *obesity, in conjunction with appropriate dietary measures. Side-effects include the production of copious oily stools and flatulence.
Health Source: Oxford | Concise Colour Medical Dictionary
Author: Jonathan Law, Elizabeth Martin

Obesity

A condition in which the energy stores of the body (mainly fat) are too large. It is a prevalent nutritional disorder in prosperous countries – increasingly so among children and young people. The Quetelet Index or BODY MASS INDEX, which relates weight in kilograms (W) to height2 in metres (H2), is a widely accepted way of classifying obesity in adults according to severity. For example:

Grade of obesity

BMI (W/H2) III >40 II 30–40 I 25–29·9 not obese <25

Causes Whatever the causes of obesity, the fact remains that energy intake (in the form of food and drink) must exceed energy output (in the form of activity and exercise) over a suf?ciently long period of time.

Obesity tends to aggregate in families. This has led to the suggestion that some people inherit a ‘thrifty’ gene which predisposes them to obesity in later life by lowering their energy output. Indeed, patients often attribute their obesity to such a metabolic defect. Total energy output is made up of the resting metabolic rate (RMR), which represents about 70 per cent of the total; the energy cost of physical activity; and thermogenesis, i.e. the increase in energy output in response to food intake, cold exposure, some drugs and psychological in?uences. In general, obese people are consistently found to have a higher RMR and total energy output, per person – and also when expressed against fat-free mass – than do their lean counterparts. Most obese people do not appear to have a reduced capacity for thermogenesis. Although a genetic component to obesity remains a possibility, it is unlikely to be great or to prevent weight loss from being possible in most patients by reducing energy intake. Environmental in?uences are believed to be more important in explaining the familial association in obesity.

An inactive lifestyle plays a minor role in the development of obesity, but it is unclear whether people are obese because they are inactive or are inactive because they are obese. For the majority of obese people, the explanation must lie in an excessive energy intake. Unfortunately, it is di?cult to demonstrate this directly since the methods used to assess how much people eat are unreliable. For most obese people it seems likely that the defect lies in their failure to regulate energy intake in response to a variety of cognitive factors (e.g. ease of ?tting of clothes) in the long term.

Unfortunately, it can be possible to identify by the time of their ?rst birthday, many of the children destined to be obese.

Rarely, obesity has an endocrine basis and is caused by hypothyroidism (see under THYROID GLAND, DISEASES OF), HYPOPITUITARISM, HYPOGONADISM or CUSHING’S SYNDROME.

Symptoms Obesity has adverse effects on MORBIDITY and mortality (see DEATH RATE) which are greatest in young adults and increase with the severity of obesity. It is associated with an increased mortality and/or morbidity from cardiovascular disease, non-insulin-dependent diabetes mellitus, diseases of the gall-bladder, osteoarthritis, hernia, gout and possibly certain cancers (i.e. colon, rectum and prostate in men, and breast, ovary, endometrium and cervix in women). Menstrual irregularities and ovulatory failure are often experienced by obese women. Obese people are also at greater risk when they undergo surgery. With the exception of gallstone formation, weight loss will reduce these health risks.

Treatment Creation of an energy de?cit is essential for weight loss to occur, so the initial line of treatment is a slimming diet. An average de?cit of 1,000 kcal/day (see CALORIE) will produce a loss of 1 kg of fat/week and should be aimed for. Theoretically, this can be achieved by increasing energy expenditure or reducing energy intake. In practice, a low-energy diet is the usual form of treatment since attempts to increase energy expenditure, either by physical exercise or a thermogenic drug, are relatively ine?ective.

Anorectic drugs, gastric stapling and jaw-wiring are sometimes used to treat severe obesity. They are said to aid compliance with a low-energy diet by either reducing hunger (anorectic drugs) or limiting the amount of food the patient can eat. Unfortunately, the long-term e?ectiveness of gastric stapling is not known, and it is debatable whether the modest reduction in weight achieved by use of anorectic drugs is worthwhile – although a new drug, ORLISTAT, is becoming available that reduces the amount of fat absorbed from food in the gastrointestinal tract. For some grossly obese patients, jaw-wiring can be helpful, but a regain of weight once the wires are removed must be prevented. These procedures carry a risk, so should be done only if an individual’s health is in danger.... obesity

Lifestyle Medicines

Drugs used for non-health problems or for disorders that are in the grey area between a genuine health need and a desire to change a ‘lifestyle failing’ by the use of medication. Examples are: SILDENAFIL CITRATE, which is prescribed for men unable to achieve penile erection (erectile dysfunction); and ORLISTAT, a drug used to combat OBESITY.... lifestyle medicines

Weight Reduction

The process of losing excess body fat. A person who is severely overweight (see obesity) is more at risk of various illnesses, such as diabetes mellitus, hypertension (high blood pressure), and heart disease.

The most efficient way to lose weight is to eat 500–1,000 kcal (2,100–4,200 kJ) a day less than the body’s total energy requirements. Exercise also forms an extremely important part of a reducing regime, burning excess energy and improving muscle tone.

In most circumstances, drugs play little part in a weight loss programme.

However, sibutramine and orlistat may be useful adjuncts to a reducing diet and may be appropriate for some people with a high (see body mass index). Appetite suppressants related to amfetamines are not recommended.... weight reduction




Recent Searches